Effectiveness of Pulmonary Rehabilitation in Patients With Chronic Obstructive Pulmonary Disease With Different Degrees of Static Lung Hyperinflation

Archives of Physical Medicine and Rehabilitation

Volumn 99, Issue 11, 2018, Pages 2279-2286.e3

  Vanfleteren, Michiel J ^a,b   Koopman, Maud ^a   Spruit, Martijn A ^a   Pennings, Herman Jan ^c   Smeenk, Frank ^d   Pieters, Willem ^e   van den Bergh, Jan J ^f   Michels, Arent Jan ^g   Wouters, Emiel F ^a,b   Groenen, Miriam T ^a   Franssen, Frits M ^a,b   Vanfleteren, Lowie E ^a,b,h  

^a Center of expertise for chronic organ failure (Ciro)   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LAURENTIUS HOSPITAL   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e ELKERLIEK HOSPITAL   (Netherlands)

^f St Jans Gasthuis ^*  (Netherlands)

^g ST ANNA HOSPITAL   (Netherlands)

^h SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

COPD; Rehabilitation

Indexed keywords

LUTEINIZING HORMONE;

AGE; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; CONSTANT WORK RATE TEST; EXERCISE; FAT FREE MASS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERINFLATION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PULMONARY REHABILITATION; QUALITY OF LIFE; RESIDUAL VOLUME; RETROSPECTIVE STUDY; SEX DIFFERENCE; SIX MINUTE WALK TEST; ST. GEORGE RESPIRATORY QUESTIONNAIRE; WALKING DISTANCE; COMPLICATION; EVALUATION STUDY; HYPERVENTILATION; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PROCEDURES; RESPIRATORY CARE; TREATMENT OUTCOME; WALK TEST; WALKING;

AGED; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERVENTILATION; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESIDUAL VOLUME; RESPIRATORY FUNCTION TESTS; RESPIRATORY THERAPY; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WALK TEST; WALKING;

EID: 85051568691     PISSN: 00039993     EISSN: 1532821X     Source Type: Journal    
DOI: 10.1016/j.apmr.2018.05.011     Document Type: Article

References (42)

1. Vogelmeier, C.F., Criner, G.J., Martínez, F.J., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. Am J Respir Crit Care Med 195 (2017), 557–582.
2. O'Donnell, D.E., Laveneziana, P., Dyspnea and activity limitation in COPD: mechanical factors. COPD 4 (2007), 225–236.
3. O'Donnell, D.E., Laveneziana, P., Physiology and consequences of lung hyperinflation in COPD. Eur Respir Rev 15 (2006), 61–67.
4. Rossi, A., Aisanov, Z., Avdeev, S., et al. Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD. Respir Med 109 (2015), 785–802.
5. O'Donnell, D.E., Guenette, J.A., Maltais, F., Webb, K.A., et al. Decline of resting inspiratory capacity in COPD: the impact on breathing pattern, dyspnea, and ventilatory capacity during exercise. Chest 141 (2012), 753–762.
6. Garcia-Rio, F., Lores, V., Mediano, O., et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 180 (2009), 506–512.
7. Ries, A.L., Make, B.J., Lee, S.M., et al. The effects of pulmonary rehabilitation in the national emphysema treatment trial. Chest 128 (2005), 3799–3809.
8. Criner, G.J., Cordova, F., Sternberg, A.L., Martinez, F.J., The National Emphysema Treatment Trial (NETT): part I: lessons learned about emphysema. Am J Respir Crit Care Med 184 (2011), 763–770.
9. O'Donnell, D.E., Lam, M., Webb, K.A., Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160 (1999), 542–549.
10. Langer, D., Ciavaglia, C.E., Neder, J.A., Webb, K.A., O'Donnell, D.E., Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med 8 (2014), 731–749.
11. Spruit, M.A., Singh, S.J., Garvey, C., et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 188 (2013), e13–e64.
12. Crisafulli, E., Venturelli, E., Biscione, G., et al. Exercise performance after standard rehabilitation in COPD patients with lung hyperinflation. Intern Emerg Med 9 (2014), 23–31.
13. Spruit, M.A., Vanderhoven-Augustin, I., Janssen, P.P., Wouters, E.F., Integration of pulmonary rehabilitation in COPD. Lancet 371 (2008), 12–13.
14. Miller, M.R., Crapo, R., Hankinson, J., et al. General considerations for lung function testing. Eur Respir J 26 (2005), 153–161.
15. van't Hul, A., Gosselink, R., Kwakkel, G., Constant-load cycle endurance performance: test-retest reliability and validity in patients with COPD. J Cardiopulm Rehabil 23 (2003), 143–150.
16. Hernandes, N.A., Wouters, E.F., Meijer, K., Annegarn, J., Pitta, F., Spruit, M.A., Reproducibility of 6-minute walking test in patients with COPD. Eur Respir J 38 (2011), 261–267.
17. Holland, A.E., Spruit, M.A., Troosters, T., et al. An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease. Eur Respir J 44 (2014), 1428–1446.
18. Singh, S.J., Puhan, M.A., Andrianopoulos, V., et al. An official systematic review of the European Respiratory Society/American Thoracic Society: measurement properties of field walking tests in chronic respiratory disease. Eur Respir J 44 (2014), 1447–1478.
19. Jones, P.W., Quirk, F.H., Baveystock, C.M., Littlejohns, P., A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145 (1992), 1321–1327.
20. Laviolette, L., Bourbeau, J., Bernard, S., et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax 63 (2008), 115–121.
21. Jones, P.W., Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 19 (2002), 398–404.
22. Vanfleteren, L.E., Spruit, M.A., Groenen, M.T., et al. Arterial stiffness in patients with COPD: the role of systemic inflammation and the effects of pulmonary rehabilitation. Eur Respir J 43 (2014), 1306–1315.
23. Chaplin, E., Latimer, L., Efficacy of lower-limb muscle training modalities in severely dyspnoeic individuals with COPD and quadriceps muscle weakness: results from the DICES trial. Thorax 69 (2014), 525–531.
24. Hartman, J.E., Klooster, K., Ten Hacken, N.H., Slebos, D.J., Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis 9 (2015), 251–259.
25. Klooster, K., ten Hacken, N.H., Hartman, J.E., Kerstjens, H.A., van Rikxoort, E.M., Slebos, D.J., Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med 373 (2015), 2325–2335.
26. Jones, P.W., Activity limitation and quality of life in COPD. COPD 4 (2007), 273–278.
27. Gea, J., Agusti, A., Roca, J., Pathophysiology of muscle dysfunction in COPD. J Appl Physiol (1985) 114 (2013), 1222–1234.
28. Barreiro, E., Gea, J., Respiratory and limb muscle dysfunction in COPD. COPD 12 (2015), 413–426.
29. Donaldson, A.V., Maddocks, M., Martolini, D., Polkey, M.I., Man, W.D., Muscle function in COPD: a complex interplay. Int J Chron Obstruct Pulmon Dis 7 (2012), 523–535.
30. Barreiro, E., Sznajder, J.I., Nader, G.A., Budinger, G.R., Muscle dysfunction in patients with lung diseases: a growing epidemic. Am J Respir Crit Care Med 191 (2015), 616–619.
31. Foreman, M.G., Zhang, L., Murphy, J., et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med 184 (2011), 414–420.
32. Steiner, M.C., Roberts, C.M., Pulmonary rehabilitation: the next steps. Lancet Respir Med 4 (2016), 172–173.
33. Spruit, M.A., Augustin, I.M., Vanfleteren, L.E., et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J 46 (2015), 1625–1635.
34. Andrianopoulos, V., Wagers, S.S., Groenen, M.T., et al. Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD. BMC Pulm Med, 14, 2014, 97.
35. Neder, J.A., Jones, P.W., Nery, L.E., Whipp, B.J., Determinants of the exercise endurance capacity in patients with chronic obstructive pulmonary disease. The power-duration relationship. Am J Respir Crit Care Med 162:2 Pt 1 (2000), 497–504.
36. Whipp, B.J., Ward, S.A., Quantifying intervention-related improvements in exercise tolerance. Eur Respir J 33 (2009), 1254–1260.
37. van der Vaart, H., Murgatroyd, S.R., Rossiter, H.B., Chen, C., Casaburi, R., Porszasz, J., Selecting constant work rates for endurance testing in COPD: the role of the power-duration relationship. COPD 11 (2014), 267–276.
38. Maatman, R.C., Spruit, M.A., van Melick, P.P., et al. Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD. Respirology 21 (2016), 483–488.
39. Sava, F., Laviolette, L., Bernard, S., Breton, M.J., Bourbeau, J., Maltais, F., The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med, 10, 2010, 55.
40. Ofir, D., Laveneziana, P., Webb, K.A., O'Donnell, D.E., Ventilatory and perceptual responses to cycle exercise in obese women. J Appl Physiol (1985) 102 (2007), 2217–2226.
41. Man, W.D., Soliman, M.G., Gearing, J., Symptoms and quadriceps fatigability after walking and cycling in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 168 (2003), 562–567.
42. Spruit, M.A., Pitta, F., Garvey, C., et al. Differences in content and organisational aspects of pulmonary rehabilitation programmes. Eur Respir J 43 (2014), 1326–1337.